Search Results - "Warlick, E"

Refine Results
  1. 1

    Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival by Lunde, L E, Dasaraju, S, Cao, Q, Cohn, C S, Reding, M, Bejanyan, N, Trottier, B, Rogosheske, J, Brunstein, C, Warlick, E, Young, J A H, Weisdorf, D J, Ustun, C

    Published in Bone marrow transplantation (Basingstoke) (01-11-2015)
    “…Although hemorrhagic cystitis (HC) is a common complication of allogeneic hematopoietic cell transplantation (alloHCT), its risk factors and effects on…”
    Get full text
    Journal Article
  2. 2

    Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival by Rogosheske, J R, Fargen, A D, DeFor, T E, Warlick, E, Arora, M, Blazar, B R, Weisdorf, D J, Brunstein, C G

    Published in Bone marrow transplantation (Basingstoke) (01-01-2014)
    “…We studied whether early CsA trough levels were associated with the risk of acute GVHD in 337 patients after either sibling PBSC or double umbilical cord blood…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation by Bejanyan, N, Oran, B, Shanley, R, Warlick, E, Ustun, C, Vercellotti, G, Verneris, M, Wagner, J E, Weisdorf, D, Brunstein, C

    Published in Bone marrow transplantation (Basingstoke) (01-08-2014)
    “…AML relapse remains the leading cause of transplant failure among Allo-SCT recipients. A single institution study was conducted on 348 patients with AML who…”
    Get full text
    Journal Article
  5. 5

    Myelodysplastic syndromes: review of pathophysiology and current novel treatment approaches by Warlick, E D, Smith, B D

    Published in Current cancer drug targets (01-09-2007)
    “…Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal disorders of hematopoietic progenitors manifest by cytopenias, bleeding, infection, and…”
    Get more information
    Journal Article
  6. 6

    Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD by He, F, Warlick, E, Miller, J S, MacMillan, M, Verneris, M R, Cao, Q, Weisdorf, D

    Published in Bone marrow transplantation (Basingstoke) (01-08-2016)
    “…Donor lymphocyte infusion (DLI) is an option for relapsed hematologic malignancies or incomplete chimerism of non-malignant diseases following allogeneic…”
    Get full text
    Journal Article
  7. 7

    MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes by Pourhassan, H, DeFor, T, Trottier, B, Dolan, M, Brunstein, C, Bejanyan, N, Ustun, C, Warlick, E D

    Published in Bone marrow transplantation (Basingstoke) (01-04-2017)
    “…Myelodysplastic syndrome (MDS) is a heterogeneous group of hematological malignancies with considerably variable prognoses and curable only with hematopoietic…”
    Get full text
    Journal Article
  8. 8

    Novel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome by Trottier, B J, Sachs, Z, DeFor, T E, Shune, L, Dolan, M, Weisdorf, D J, Ustun, C, Warlick, E D

    Published in Bone marrow transplantation (Basingstoke) (01-02-2016)
    “…Among patients with myelodysplastic syndrome (MDS) undergoing hematopoietic cell transplantation (HCT), the impact of residual pretransplant cytogenetically…”
    Get full text
    Journal Article
  9. 9

    Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML by Ustun, C, Wiseman, A C, DeFor, T E, Yohe, S, Linden, M A, Oran, B, Burke, M, Warlick, E, Miller, J S, Weisdorf, D

    Published in Bone marrow transplantation (Basingstoke) (01-11-2013)
    “…Reduced-intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (allo-HCT) can cure patients with AML in CR. However, relapse after RIC…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Reduced-intensity hematopoietic cell transplantation in older patients with AML MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors by Majhail, N S, Brunstein, C G, Shanley, R, Sandhu, K, McClune, B, Oran, B, Warlick, E D, Wagner, J E, Weisdorf, D J

    Published in Bone marrow transplantation (Basingstoke) (01-04-2012)
    “…Umbilical cord blood (UCB) has increased access to hematopoietic cell transplantation (HCT) for patients without HLA-matched sibling donors (MSD). We compared…”
    Get full text
    Journal Article
  12. 12

    Similar outcomes between adolescent/young adults and children with AML following allogeneic hematopoietic cell transplantation by Burke, M J, Gossai, N, Cao, Q, MacMillan, M L, Warlick, E, Verneris, M R

    Published in Bone marrow transplantation (Basingstoke) (01-02-2014)
    “…We recently reported that adolescents and young adults (AYAs) with B-cell ALL receiving allogeneic hematopoietic cell transplantation (allo-HCT) have inferior…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    The effect of equine antithymocyte globulin on the outcomes of reduced intensity conditioning for AML by Hagen, P, Wagner, J E, DeFor, T E, Dolan, M, Arora, M, Warlick, E, Weisdorf, D, Brunstein, C G

    Published in Bone marrow transplantation (Basingstoke) (01-12-2014)
    “…Whether or not the benefits of antithymocyte globulin (ATG) on engraftment and GVHD are offset by increased risk of relapse, delayed T-cell recovery and…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Accessibility and Disability Services in Virginia’s Four-Year Academic Libraries: A Content Analysis of Library Webpages by Vaughan, K. T. L., Warlick, Stefanie E.

    Published in Virginia libraries (Alexandria, Va.) (02-06-2020)
    “…Academic libraries serve a wide range of students, faculty, and staff with diverse needs for library accessibility, including people with temporary and chronic…”
    Get full text
    Journal Article
  18. 18

    Mechanistic Diversity in the RuBisCO Superfamily: RuBisCO from Rhodospirillum rubrum Is Not Promiscuous for Reactions Catalyzed by RuBisCO-like Proteins by Warlick, Benjamin P. E, Imker, Heidi J, Sriram, Jaya, Tabita, F. Robert, Gerlt, John A

    Published in Biochemistry (Easton) (27-11-2012)
    “…d-Ribulose 1,5-bisphosphate carboxylase/oxygenases (RuBisCOs) are promiscuous, catalyzing not only carboxylation and oxygenation of d-ribulose 1,5-bisphosphate…”
    Get full text
    Journal Article
  19. 19

    Factors influencing publication choice: why faculty choose open access by Warlick, Stefanie E, Vaughan, Ktl

    Published in Biomedical digital libraries (09-03-2007)
    “…In an attempt to identify motivating factors involved in decisions to publish in open access and open archives (OA) journals, individual interviews with…”
    Get full text
    Journal Article
  20. 20

    Finding Articles and Journals via Google Scholar, Journal Portals, and Link Resolvers: Usability Study Results by Dixon, Lydia, Duncan, Cheri, Fagan, Jody Condit, Mandernach, Meris, Warlick, Stefanie E.

    Published in Reference and user services quarterly (22-12-2010)
    “…Finding journal titles and journal articles are two of the toughest tasks on academic library webpages. Challenges include choosing the best tools, using terms…”
    Get full text
    Journal Article